Prenatal exposure to epidermal growth factor attenuates respiratory distress syndrome in rhesus infants

B. W. Goetzman, L. C. Read, Charles Plopper, Alice F Tarantal, C. George-Nascimento, T. A. Merritt, J. A. Whitsett, Dennis M Styne

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Treatment of nonhuman primate fetuses with epidermal growth factor (EGF) results in histologic and biochemical maturation of their lungs. To determine whether these effects improve lung function postnatally, we studied premature rhesus infants delivered at 78% of gestation after in utero treatment with EGF (n = 5) or placebo (n = 5). Indices of lung function during the 4 d of postnatal care included fractional concentration of inspired oxygen, peak inspiratory pressure, ventilator rate, mean airway pressure, arterial to alveolar oxygen tension ratio, and ventilation index. Statistically significant differences were noted in the time courses of these variables between EGF- and placebo-treated infants. The direction of the differences indicated that the EGF-treated infants had less severe lung disease. Surfactant apoprotein A concentration and lecithin to sphingomyelin ratio were both significantly higher in the amniotic fluid of the EGF-treated group, indicating advanced biochemical maturation in this group of animals. Whereas birth weight was not affected by EGF exposure, adrenal and gut weights, standardized for body weight, were increased significantly. Histologic studies showed advanced cellular maturation with increased parenchymal airspace and decreased parenchymal tissue space in the EGF- treated group compared with the control group. We conclude that prenatal exposure to EGF stimulates biochemical and histologic maturation of the lung and markedly attenuates the clinical severity of respiratory disease in this model of simian respiratory distress syndrome.

Original languageEnglish (US)
Pages (from-to)30-36
Number of pages7
JournalPediatric Research
Volume35
Issue number1
StatePublished - 1994

Fingerprint

Epidermal Growth Factor
Lung
Placebos
Postnatal Care
Oxygen
Apoproteins
Sphingomyelins
Lecithins
Amniotic Fluid
Mechanical Ventilators
Birth Weight
Premature Infants
Surface-Active Agents
Primates
Lung Diseases
Ventilation
Arterial Pressure
Fetus
Body Weight
Pressure

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Prenatal exposure to epidermal growth factor attenuates respiratory distress syndrome in rhesus infants. / Goetzman, B. W.; Read, L. C.; Plopper, Charles; Tarantal, Alice F; George-Nascimento, C.; Merritt, T. A.; Whitsett, J. A.; Styne, Dennis M.

In: Pediatric Research, Vol. 35, No. 1, 1994, p. 30-36.

Research output: Contribution to journalArticle

Goetzman, BW, Read, LC, Plopper, C, Tarantal, AF, George-Nascimento, C, Merritt, TA, Whitsett, JA & Styne, DM 1994, 'Prenatal exposure to epidermal growth factor attenuates respiratory distress syndrome in rhesus infants', Pediatric Research, vol. 35, no. 1, pp. 30-36.
Goetzman, B. W. ; Read, L. C. ; Plopper, Charles ; Tarantal, Alice F ; George-Nascimento, C. ; Merritt, T. A. ; Whitsett, J. A. ; Styne, Dennis M. / Prenatal exposure to epidermal growth factor attenuates respiratory distress syndrome in rhesus infants. In: Pediatric Research. 1994 ; Vol. 35, No. 1. pp. 30-36.
@article{d2ef9ca9df1c44f59c7f2f1bd8082e78,
title = "Prenatal exposure to epidermal growth factor attenuates respiratory distress syndrome in rhesus infants",
abstract = "Treatment of nonhuman primate fetuses with epidermal growth factor (EGF) results in histologic and biochemical maturation of their lungs. To determine whether these effects improve lung function postnatally, we studied premature rhesus infants delivered at 78{\%} of gestation after in utero treatment with EGF (n = 5) or placebo (n = 5). Indices of lung function during the 4 d of postnatal care included fractional concentration of inspired oxygen, peak inspiratory pressure, ventilator rate, mean airway pressure, arterial to alveolar oxygen tension ratio, and ventilation index. Statistically significant differences were noted in the time courses of these variables between EGF- and placebo-treated infants. The direction of the differences indicated that the EGF-treated infants had less severe lung disease. Surfactant apoprotein A concentration and lecithin to sphingomyelin ratio were both significantly higher in the amniotic fluid of the EGF-treated group, indicating advanced biochemical maturation in this group of animals. Whereas birth weight was not affected by EGF exposure, adrenal and gut weights, standardized for body weight, were increased significantly. Histologic studies showed advanced cellular maturation with increased parenchymal airspace and decreased parenchymal tissue space in the EGF- treated group compared with the control group. We conclude that prenatal exposure to EGF stimulates biochemical and histologic maturation of the lung and markedly attenuates the clinical severity of respiratory disease in this model of simian respiratory distress syndrome.",
author = "Goetzman, {B. W.} and Read, {L. C.} and Charles Plopper and Tarantal, {Alice F} and C. George-Nascimento and Merritt, {T. A.} and Whitsett, {J. A.} and Styne, {Dennis M}",
year = "1994",
language = "English (US)",
volume = "35",
pages = "30--36",
journal = "Pediatric Research",
issn = "0031-3998",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Prenatal exposure to epidermal growth factor attenuates respiratory distress syndrome in rhesus infants

AU - Goetzman, B. W.

AU - Read, L. C.

AU - Plopper, Charles

AU - Tarantal, Alice F

AU - George-Nascimento, C.

AU - Merritt, T. A.

AU - Whitsett, J. A.

AU - Styne, Dennis M

PY - 1994

Y1 - 1994

N2 - Treatment of nonhuman primate fetuses with epidermal growth factor (EGF) results in histologic and biochemical maturation of their lungs. To determine whether these effects improve lung function postnatally, we studied premature rhesus infants delivered at 78% of gestation after in utero treatment with EGF (n = 5) or placebo (n = 5). Indices of lung function during the 4 d of postnatal care included fractional concentration of inspired oxygen, peak inspiratory pressure, ventilator rate, mean airway pressure, arterial to alveolar oxygen tension ratio, and ventilation index. Statistically significant differences were noted in the time courses of these variables between EGF- and placebo-treated infants. The direction of the differences indicated that the EGF-treated infants had less severe lung disease. Surfactant apoprotein A concentration and lecithin to sphingomyelin ratio were both significantly higher in the amniotic fluid of the EGF-treated group, indicating advanced biochemical maturation in this group of animals. Whereas birth weight was not affected by EGF exposure, adrenal and gut weights, standardized for body weight, were increased significantly. Histologic studies showed advanced cellular maturation with increased parenchymal airspace and decreased parenchymal tissue space in the EGF- treated group compared with the control group. We conclude that prenatal exposure to EGF stimulates biochemical and histologic maturation of the lung and markedly attenuates the clinical severity of respiratory disease in this model of simian respiratory distress syndrome.

AB - Treatment of nonhuman primate fetuses with epidermal growth factor (EGF) results in histologic and biochemical maturation of their lungs. To determine whether these effects improve lung function postnatally, we studied premature rhesus infants delivered at 78% of gestation after in utero treatment with EGF (n = 5) or placebo (n = 5). Indices of lung function during the 4 d of postnatal care included fractional concentration of inspired oxygen, peak inspiratory pressure, ventilator rate, mean airway pressure, arterial to alveolar oxygen tension ratio, and ventilation index. Statistically significant differences were noted in the time courses of these variables between EGF- and placebo-treated infants. The direction of the differences indicated that the EGF-treated infants had less severe lung disease. Surfactant apoprotein A concentration and lecithin to sphingomyelin ratio were both significantly higher in the amniotic fluid of the EGF-treated group, indicating advanced biochemical maturation in this group of animals. Whereas birth weight was not affected by EGF exposure, adrenal and gut weights, standardized for body weight, were increased significantly. Histologic studies showed advanced cellular maturation with increased parenchymal airspace and decreased parenchymal tissue space in the EGF- treated group compared with the control group. We conclude that prenatal exposure to EGF stimulates biochemical and histologic maturation of the lung and markedly attenuates the clinical severity of respiratory disease in this model of simian respiratory distress syndrome.

UR - http://www.scopus.com/inward/record.url?scp=0028044947&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028044947&partnerID=8YFLogxK

M3 - Article

C2 - 8134196

AN - SCOPUS:0028044947

VL - 35

SP - 30

EP - 36

JO - Pediatric Research

JF - Pediatric Research

SN - 0031-3998

IS - 1

ER -